Menu

David SIEGRIST

LYON

En résumé

CFO Pharma/Biotechnology/New technology with scientific background
- International background, working with French, European and American companies, large and small corporations
- IPO management (CFO of Spineway listed in February 2013 on Euronext Paris Alternext)
- Investors relation
- Banks relation
- R&D Tax Credit advanced skills (French rules), tax optimisation, grants management (French and European)
- Implementation of reporting and follow-up systems (sales, margins, projects)
- Implementation of budget procedures
- Accounting expertise : Monitoring monthly and annual close ; knowledge in IFRS & US GAAP
- Day to day cash management
- Internal control : implementation of corporate procedures
- Implementation of purchasing policies
- Management of teams up to 6 employees

Entreprises

  • Spineway - CFO

    2012 - maintenant
  • PX Therapeutics - CFO

    Grenoble 2009 - 2012
  • EUSA Pharma - European Financial Controller

    2006 - 2008
  • Serono Genetics Institute - Financial Controller

    2003 - 2005
  • Merial - European Financial Controller for the Information System Dept.

    Lyon 1999 - 2003
  • Merial - Projects Planner Manager for European R&D Department

    Lyon 1995 - 1999
  • Indépendant - Finance consultant

    1993 - 1994
  • Cayla - Product manager

    Villefranche-de-Rouergue 1991 - 1992

Formations

Pas de formation renseignée

Réseau

Annuaire des membres :